Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Regeneron Pharmaceuticals Unusual Options Activity
Tickers REGN
Tags BZI/UOA REGN Market News
From Benzinga
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking
Tickers REGN
Tags Market News Benzinga Markets
From Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
Tickers REGN
Tags Short Ideas REGN Trading Ideas
From Benzinga
Check Out What Whales Are Doing With REGN
Tickers REGN
Tags REGN BZI/UOA Benzinga
From Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Tickers NEWS REGN SNY
Tags Briefs REGN Biotech
From Benzinga
28 Analysts Have This To Say About Regeneron Pharmaceuticals
Tickers REGN
Tags BZI/AAR REGN Analyst Ratings
From Benzinga
2 Top Growth Stocks to Buy on the Dip
Tickers LLY REGN
Tags REGN Market News Recent Press Releases
From Motley Fool
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
Tickers AZN GSK NEWS REGN
Tags Stories That Matter Benzinga Biotech
From Benzinga
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
Tickers NEWS REGN
Tags News REGN BZI/IA
From Benzinga
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
Tickers ASML DELL IDXX MRNA
Tags ASML MRNA Market News
From Motley Fool
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
Tickers AMGN AZN NEWS REGN
Tags News SNY Trading Ideas
From Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
Tickers REGN
Tags Benzinga Options Markets
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
Tickers NEWS NVO REGN SNY
Tags News Large Cap SNY
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags MRK BMY XLU
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags AMGN Health Care YMAB
From Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
Tickers EYPT NEWS REGN
Tags Market News why it's moving Health Care
From Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Tickers AMGN CMG GS LLY
Tags Recent Press Releases GS AMGN
From Motley Fool
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
Tickers LLY NEWS REGN SNY
Tags Biotech Stories That Matter Benzinga
From Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $5,800 Today
Tickers NEWS REGN
Tags REGN News Benzinga
From Benzinga
A Closer Look at 23 Analyst Recommendations For Regeneron Pharmaceuticals
Tickers REGN
Tags BZI/AAR Analyst Ratings REGN
From Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
Tickers NEWS REGN
Tags Trading Ideas Benzinga BZI/IA
From Benzinga
Seagate To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Wednesday
Tickers MCD MCO NEWS NSC
Tags WTFC STX MCO
From Benzinga
Market Whales and Their Recent Bets on REGN Options
Tickers REGN
Tags BZI/UOA REGN Market News
From Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
Tickers NEWS REGN
Tags Market News BZI/POD Benzinga
From Benzinga
What the Options Market Tells Us About Regeneron Pharmaceuticals
Tickers REGN
Tags REGN BZI/UOA Benzinga
From Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Tickers AMGN AZN BMRN GILD
Tags Biotech VRTX Stories That Matter
From Benzinga
Inquiry Into Regeneron Pharmaceuticals's Competitor Dynamics In Biotechnology Industry
Tickers NEWS REGN
Tags Market News Markets BZI/IA
From Benzinga
Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs
Tickers LLY NEWS NVO REGN
Tags AI Generated Top Stories Health Care
From Benzinga
Should You Buy the Dip on This Top Growth Stock?
Tickers AMGN REGN
Tags REGN AMGN Market News
From Motley Fool
A Closer Look at 24 Analyst Recommendations For Regeneron Pharmaceuticals
Tickers REGN
Tags BZI/AAR Analyst Ratings REGN
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.